Study guide

12.2 Thyroid & Parathyroid Disorders

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

12.2 Thyroid & Parathyroid Disorders

Key Takeaways Explain This Topic AI

Primary hypothyroidism presents with elevated TSH and low free T4, with Hashimoto thyroiditis (anti-TPO antibodies) being the leading etiology in developed nations.

Thyroid storm requires sequential treatment with beta-blockers, propylthiouracil (PTU) or methimazole, potassium iodide (given ≥1 hour post-antithyroid drug), and hydrocortisone.

A thyroid nodule with normal/high TSH requires ultrasound; nodules ≥1 cm with high-risk ultrasound features (microcalcifications, hypoechoic, irregular margins) warrant Fine Needle Aspiration (FNA).

Primary hyperparathyroidism exhibits hypercalcemia, elevated or inappropriately normal PTH, hypophosphatemia, and 24-hour urine calcium clearance >0.01.

Severe hypercalcemia (>14 mg/dL) requires immediate aggressive intravenous 0.9% normal saline hydration followed by calcitonin and bisphosphonates (zoledronic acid).

Last updated: July 2026

  • Thyroid & Parathyroid Disorders
  • Thyroid Physiology and Diagnostic Testing Interpretation

Thyroid hormone production is regulated by the hypothalamic-pituitary-thyroid axis via Thyrotropin-Releasing Hormone (TRH) and Thyroid-Stimulating Hormone (TSH) . Serum TSH is the most sensitive screening test for thyroid dysfunction due to an inverse logarithmic relationship with free thyroid hormone levels.

Interpretation of Thyroid Function Profiles

Clinical Condition TSH Level Free T4 Level Free T3 Level Clinical Features & Diagnostic Clues

Primary Hypothyroidism Elevated (>4.5 mIU/L) Low Low or Normal Fatigue, weight gain, cold intolerance, constipation, dry skin, delayed relaxation of deep tendon reflexes. Most common cause: Hashimoto thyroiditis (anti-TPO and anti-thyroglobulin antibodies positive).

Subclinical Hypothyroidism Elevated (>4.5 mIU/L) Normal Normal Asymptomatic or mild symptoms. Treat if TSH >10 mIU/L, positive anti-TPO antibodies, symptomatic, pregnant, or presence of goiter.

Primary Hyperthyroidism Suppressed (<0.1 mIU/L) Elevated Elevated Weight loss, heat intolerance, tremor, palpitations, anxiety, frequent bowel movements. Causes: Graves disease (TSI/TRAb positive, diffuse RAIU), Toxic Multinodular Goiter , Toxic Adenoma .

Subacute (de Quervain) Thyroiditis Suppressed (<0.1 mIU/L) Elevated (Early) Elevated (Early) Painful, tender thyroid goiter , post-viral prodrome, elevated ESR/CRP, markedly low radioactive iodine uptake (RAIU) .

Central Hypothyroidism Low or Normal Low Low Secondary (pituitary) or tertiary (hypothalamic) failure. Accompanied by other anterior pituitary hormone deficiencies.

Diagnostic Algorithm for Thyroid Nodules and Malignancy

Thyroid nodules are detected in up to 65% of the general population. The diagnostic goal is distinguishing benign nodules from thyroid carcinomas (papillary, follicular, medullary, anaplastic). [ Solitary Thyroid Nodule Discovered ]

  • │
  • [ Measure Serum TSH ]
  • │
  • ┌──────────────────────────────┴──────────────────────────────┐
  • [ Low TSH (Hyperthyroid) ] [ Normal or High TSH ]
  • │ │
  • [ Iodine-123 Scintigraphy ] ▼
  • │ [ Thyroid Ultrasound ]
  • ┌────────┴────────┐ │
  • ▼ ▼ ┌─────────────┴─────────────┐
  • ["Hot" Nodule] ["Cold" Nodule] │ │
  • (Hyperfunctioning) (Non-functioning) [ High-Risk Features ] [ Benign Features ]
  • │ │ (≥1 cm, microcalcif, (purely cystic,
  • ▼ └──────────────────────────────► hypoechoic, solid) sponge-like)
  • Evaluate for │ │
  • Hyperthyroidism ▼ ▼
  • (Low malignancy) [ FNA Biopsy ] [ Clinical Monitoring ]
  • Risk Stratification for Fine Needle Aspiration (FNA)

FNA Biopsy Indicated :

Nodules ≥1.0 cm with high-risk sonographic features (microcalcifications, hypoechoic texture, irregular margins, taller-than-wide shape, or extrathyroidal extension).

Nodules ≥1.5 cm with intermediate-risk features (hypoechoic solid nodules with smooth margins).

Nodules ≥2.0 cm with low-risk features (isoechoic or hyperechoic solid nodules).

Cytological Classification (Bethesda System) :

Papillary Thyroid Carcinoma : Most common (80–85%). Histology displays Orphan Annie eye nuclei , psammoma bodies, and nuclear grooves. Excellent prognosis. Lymphatic spread.

Follicular Thyroid Carcinoma : Requires capsular or vascular invasion to distinguish from follicular adenoma (FNA cannot distinguish; requires surgical excision). Hematogenous spread.

Medullary Thyroid Carcinoma : Derived from parafollicular C-cells; secretes calcitonin . Associated with MEN 2A and 2B ( RET proto-oncogene mutation). Histology displays amyloid stroma (Congo red positive).

Anaplastic Thyroid Carcinoma : Elderly patients, rapidly enlarging painful neck mass, compressive symptoms (dysphagia, hoarseness). Extremely aggressive, fatal.

Thyroid Emergencies: Thyroid Storm & Myxedema Coma

Thyroid Storm : Life-threatening hypermetabolic state triggered by surgery, infection, trauma, or iodine load in uncontrolled hyperthyroidism. Features include high fever (>104°F/40°C), severe tachycardia/atrial fibrillation, agitation, delirium, vomiting, diarrhea, and jaundice.

Management Multimodal Protocol :

Beta-Blocker : Intravenous Propranolol (blocks sympathetic surge and peripheral T4-to-T3 conversion).

Antithyroid Drug : Propylthiouracil (PTU) or Methimazole (inhibits thyroid peroxidase; PTU preferred in thyroid storm as it also blocks peripheral T4-to-T3 conversion).

Iodine Solution : Lugol's iodine or Potassium Iodide (SSKI) administered at least 1 hour AFTER antithyroid medication to prevent iodine from serving as substrate for new hormone synthesis (Wolff-Chaikoff effect).

Glucocorticoids : Hydrocortisone IV (blocks peripheral conversion of T4 to T3 and treats relative adrenal insufficiency).

Myxedema Coma : Severe end-stage hypothyroidism presenting with hypothermia, bradycardia, hypoventilation, hyponatremia, and altered mental status. Treatment involves IV Levothyroxine (T4) plus IV Hydrocortisone (to prevent adrenal crisis if coexisting adrenal insufficiency is present).

Parathyroid Disorders & Calcium Homeostasis

Calcium homeostasis is tightly regulated by Parathyroid Hormone (PTH) , 1,25-dihydroxyvitamin D (calcitriol), and calcitonin. PTH increases serum calcium by increasing bone resorption, enhancing renal distal tubule calcium reabsorption, and stimulating 1-alpha-hydroxylase in the kidney to synthesize active Vitamin D.

Disorder Serum Calcium Serum Phosphate Serum PTH 24-Hour Urine Calcium Key Clinical Features & Management

Primary Hyperparathyroidism Elevated Low or Normal Elevated or Inappropriate Normal Elevated (>250 mg/day; Ca clearance ratio >0.01) Parathyroid adenoma (85%). "Stones, bones, abdominal groans, psychiatric overtones." Subperiosteal bone resorption. Surgery indicated if age <50, Ca >1.0 mg/dL above normal, eGFR <60, or T-score <-2.5.

Familial Hypocalciuric Hypercalcemia (FHH) Elevated Normal or Low Normal or Slightly Elevated Low (Urine Ca clearance ratio <0.01) Inactivating mutation of Calcium-Sensing Receptor (CaSR). Benign condition; surgery is contraindicated.

Hypercalcemia of Malignancy Elevated Low or High Suppressed (<10 pg/mL) Elevated 1. PTHrP secretion (squamous cell lung, renal, head/neck). 2. Osteolytic metastases (breast, multiple myeloma). 3. 1,25-OH2 Vit D excess (lymphoma, sarcoidosis).

Hypoparathyroidism Low Elevated Low or Undetectable Low Postsurgical removal/damage during thyroidectomy (most common). Signs: Chvostek sign (facial twitching), Trousseau sign (carpopedal spasm), prolonged QT. Tx: Oral Ca + Calcitriol. Emergency: IV Calcium Gluconate.

Emergency Management of Severe Hypercalcemia (>14 mg/dL or Symptomatic)

Intravenous Hydration : Administer aggressive IV 0.9% Normal Saline (200–500 mL/hr) to restore intravascular volume and promote renal calcium excretion.

Calcitonin : Administer subcutaneous/IV calcitonin for rapid lowering of serum calcium within 2–4 hours (inhibits osteoclast activity; limited by tachyphylaxis after 48 hours).

Bisphosphonates : Infuse Zoledronic acid or Pamidronate for long-term inhibition of bone resorption (onset of action in 2–4 days). Calcitonin serves as a bridge until bisphosphonates take effect.